http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101242428-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10 |
| filingDate | 2006-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101242428-B1 |
| titleOfInvention | Dermatological Uses of Milk Proteins |
| abstract | The present invention provides a method for treating acne comprising orally administering to a person suffering from acne an effective amount of a lactoferrin-containing whey protein and preferably a fraction further containing the specific whey protein. The lactoferrin is preferably native bovine lactoferrin and the whey protein fraction is administered at a level of 10 mg to 2 g per patient per day.n n n Acne, Skin, Lactoferrin, Whey, Protein |
| priorityDate | 2005-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.